Illumina, Nashville Biosciences Ink WGS Agreement With Amgen for African American Cohort
As part of the agreement, Amgen subsidiary DeCode Genetics will perform WGS on 35,000 DNA samples from VUMC's biobank using Illumina platforms.
Genuity Science Gains Access to BioVU With Nashville Biosciences Deal
Genuity, formerly known as WuXi NextCode, will sequence, analyze, and harmonize samples from Vanderbilt's biobank to inform biomarker and drug discovery.
PMI Biopharma, Nashville Biosciences Form Drug Development Services Alliance
The companies have agreed to combine their respective offerings into a single services package for drug target identification and validation.